Price
No data yet.
Social Signal Score
Revenue
$48.86M+94.72%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Mark Steven Fogel
- Sector
- Real Estate
- Industry
- REIT - Mortgage
- Employees
- 4
- Beta
- 1.06
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- -0.20
Financials
Revenue
$48.86M+94.7%Net Income
$-7.42MEBITDA
$22.88MFree Cash Flow
$5.47MEPS (diluted)
$-1.87Shares Outstanding (diluted)
6.69M-34.2%Operating Expenses
$2.72MCash & Debt
$41.95MReturn of Capital
$5.12MRevenue by Segment (annual)
$125.36MDividend per Share
$0.82Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $165.90M | $21.32M | $0.03 |
| 2024 | $83.49M | $29.27M | $1.19 |
| 2023 | $91.13M | $22.39M | $0.35 |
| 2022 | $62.88M | $10.62M | $-1.00 |
| 2021 | $106.43M | $33.92M | $1.85 |
| 2020 | $-80.86M | $-197.71M | $-19.33 |
| 2019 | $56.47M | $35.97M | $2.46 |
| 2018 | $36.62M | $27.43M | $0.66 |
| 2017 | $45.96M | $33.54M | $0.54 |
| 2016 | $62.68M | $-30.36M | $-5.19 |
| 2015 | $123.92M | $10.55M | $0.98 |
| 2014 | $112.30M | $61.20M | $4.08 |
| 2013 | $91.59M | $46.45M | $3.96 |
| 2012 | $107.72M | $64.44M | $8.52 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ACR's reported EPS growth of -34.7% a year over 13 years. Historical EPS growth of -35% would project the company towards zero. Floored at -15% as a starting point.
- EPS in 5 years
- $1.33
- Implied price
- $23.88
- Return from $14.28
- 10.8% a year
To earn 15.0% a year on these assumptions you'd need to buy at $11.87 — -16.9% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -25.0% | -9.8% | -5.7% | -2.2% | 0.9% | 3.6% |
| -20.0% | -3.8% | 0.6% | 4.3% | 7.6% | 10.5% |
| -15.0% | 2.2% | 6.9% | 10.8% | 14.3% | 17.4% |
| -10.0% | 8.2% | 13.1% | 17.4% | 21.0% | 24.3% |
| -5.0% | 14.2% | 19.4% | 23.9% | 27.7% | 31.2% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
80Social Signal Score
Mentions (1)
- Newsglobenewswire.com·1d ago·Negative
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026 SOUTH SAN FRANCISCO, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biotechnology company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its selection for three scientific presentations at ACR Convergence 2026 being held November 6-11 in Orlando.
View source ↗
Earnings
Wed, Nov 4(in 8 weeks)
Consensus estimate $0.15 per share
Typical surprise -55.6% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$-0.74 vs $0.18miss
- Thu, Apr 30$0.02 vs $0.04miss
- Wed, Mar 4$-0.48 vs $0.14miss
- Wed, Oct 29$1.01 vs $0.14beat
- Wed, Jul 30$0.04 vs $0.01beat
- Wed, Apr 30$-0.86 vs $0.53miss
Estimates and results for ACR via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ACR officers and directors.
- Bought
- —
- Sold
- $2.6m
0 trades
73 trades
- Eagle Point Credit Management Llcsold
- Eagle Point Credit Management Llcsold
- Eagle Point Credit Management Llcsold
- Eagle Point Credit Management Llcsold
- Eagle Point Credit Management Llcsold
- Eagle Point Credit Management Llcsold
- Eagle Point Credit Management Llcsold
- Eagle Point Credit Management Llcsold
27 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.